Transcatheter Embolization and Occlusion (TEO) Devices Market Gross Margin Analysis, Global Overview, Emerging Trends, Leading Growth Drivers, Future Estimation and Industry Outlook 2023

August 30 13:41 2019
Transcatheter Embolization and Occlusion (TEO) Devices Market Gross Margin Analysis, Global Overview, Emerging Trends, Leading Growth Drivers, Future Estimation and Industry Outlook 2023

Transcatheter Embolization and Occlusion (TEO) Devices Market
The global Transcatheter Embolization and Occlusion (TEO) Devices Market study also includes the key strategic developments of the , comprising R&D, new product launch, agreements, collaborations, partnerships, joint ventures, Global and regional growth of the leading competitors operating in the market on a global and regional scale. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with Transcatheter Embolization and Occlusion (TEO) Devices industry segm

Market Highlights

The Global Transcatheter Embolization and Occlusion (TEO) Devices Market held a Market Value of USD 3,290.4 million in 2018 and is Projected to Grow at a CAGR of 9.9% Over the Forecast Period.

A catheter embolization procedure involves medications, or synthetic materials (embolic agents) are inserted through a catheter into a blood vessel to prevent blood flow to the area. Factors contributing to the market growth are technological advances in the products, expansion of the target patient population base, surging number of minimally invasive surgeries, the presence of favorable reimbursement for cardiovascular surgeries. On the other hand, costlier products and the presence of stringent regulatory framework for product commercialization are anticipated to limit the market growth during the next five years.

Fill Out Details To Receive FREE Sample Here:

https://www.marketresearchfuture.com/sample_request/7864

Transcatheter embolization and occlusion (TEO) is a minimally invasive alternative to an open surgery thereby shifting the preference of patients towards minimally invasive surgeries as it offers several advantages including minor incisions & tissue damage, minimal pain & surgical scars, same day discharge from the healthcare settings, and speedy wound healing. Overall, this can cause minor complications and reduces surgery costs that are likely to foster market growth during the next nine years.

Technology is proving its efficiency in treatment while performing complex surgeries. Embolization technique has become one of the most popular modalities for treatment of various types of cancer such as kidney, breast, liver (hepatocellular carcinoma), pancreatic, among others.

The introduction of technically advanced products with enhanced efficiency to treat malformations and fibrosis is supporting the market growth. For instance, in January 2018, the Cerenovus division of Johnson & Johnson Services, Inc. introduced the Galaxy G3 Mini embolic coil to remove clots from brain post ischemic strokes.

Key Players

Few of the prominent players in the global Transcatheter Embolization and Occlusion (TEO) Devices Market are, Pfizer Inc., DePuy Synthes, Cardinal Health, Cook Medical, Sirtex Medical Limited, and Merit Medical Systems.

Access Report Details @ https://www.marketresearchfuture.com/reports/transcatheter-embolization-and-occlusion-devices-market-7864

Regional Analysis

The Global Transcatheter Embolization and Occlusion (TEO) Devices Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of medical reimbursements for cardiovascular procedures and key original equipment manufacturers which facilitates early market initiation, established healthcare infrastructure, and skilled healthcare professionals. These players include Stryker Corporation, Boston Scientific Corporation, Pfizer Inc., Abbott Laboratories, and Cardinal Health.

Europe would follow the Americas in terms of value in the Transcatheter Embolization and Occlusion (TEO) Devices Market as medical devices make an essential contribution to healthcare in the European Union for the benefit of European citizens. In addition, strong growth in radioembolization spheres, drug-eluting beads, and flow-diverting devices would support the regional market growth.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period owing to growing geriatric population coupled with rising burden of venous malformations and vascular anomalies, rapidly growing medical tourism in emerging countries including India, Australia, China, and Malaysia.

The Middle East & Africa has the least share of the global transcatheter embolization and occlusion devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global Transcatheter Embolization and Occlusion (TEO) Devices Market has been segmented into product, indication, end user, and region.

By product, the market has been segmented into coiled devices and non-coiled devices. The coiled devices segment has been further categorized into pushable coils and detachable coils. The non-coiled devices segment has been additionally divided into flow diverting devices, embolization particles, liquid embolic, other embolization and occlusion devices, and accessories. The accessories segment is expected to hold the largest share among non-coiled devices throughout the forecast period due to the introduction of various accessories along with the wide availability of embolization products.

On the basis of indication, the market has been divided into peripheral vascular disease, oncology, neurology, urology, and others.

Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/transcatheter-embolization-and-occlusion-devices-market-7864